Sarepta or Amarin: Who Is Controlling Expenses Better?
Sarepta and Amarin: How These Biotech Stocks Stack Up(Continued from Prior Part)Growth catalysts In its fourth-quarter earnings conference call, Sarepta Therapeutics (SRPT) highlighted its submission of an NDA (new drug application) in the fourth